-+ 0.00%
-+ 0.00%
-+ 0.00%

10x Genomics Expands Autoimmune Biomarker Research With Two New Collaborations

PUBT·11/16/2026 21:07:36
10x Genomics Expands Autoimmune Biomarker Research With Two New Collaborations
  • 10x Genomics announced two research collaborations to identify blood-based biomarkers for autoimmune disease activity and treatment response, expanding research into Europe and Asia.
  • Both collaborations plan to use Flex Apex to analyze blood samples over time at single-cell resolution, linking immune profiles with clinical outcomes.
  • Charité and DRFZ plan a multiyear study involving 750 patients with rheumatoid arthritis, lupus or psoriatic arthritis to identify disease-activity and treatment-response biomarkers.
  • Seoul National University researchers will study moderate-to-severe alopecia areata, seeking biomarkers that predict response to JAK inhibitor therapy.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 10x Genomics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611161605PR_NEWS_USPR_____LA98803) on November 16, 2026, and is solely responsible for the information contained therein.